coniferaldehyde has been researched along with Dermatitis, Atopic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, EJ; Choi, EY; Choi, H; Choi, HG; Jeong, GS; Jun, CD; Kim, HR; Kwon, MS; Lee, HS; Lee, KS; Na, BR | 1 |
1 other study(ies) available for coniferaldehyde and Dermatitis, Atopic
Article | Year |
---|---|
Oral Administration of 4-Hydroxy-3-Methoxycinnamaldehyde Attenuates Atopic Dermatitis by Inhibiting T Cell and Keratinocyte Activation.
Topics: Acrolein; Administration, Oral; Animals; Cell Differentiation; Cell Proliferation; Cytokines; Dermatitis, Atopic; Dinitrochlorobenzene; Female; GATA3 Transcription Factor; Gene Expression; Inflammation Mediators; Keratinocytes; Mice, Inbred BALB C; Mice, Inbred C57BL; Mites; Reverse Transcriptase Polymerase Chain Reaction; T-Box Domain Proteins; T-Lymphocytes; Th1 Cells; Th2 Cells | 2015 |